Association of polymorphism in the human μ-opioid receptor OPRM1 gene with proinflammatory cytokine levels and health perception

Brain, Behavior, and Immunity

Volumn 23, Issue 7, 2009, Pages 931-935

  Matsunaga, Masahiro ^a,b   Isowa, Tokiko ^c   Murakami, Hiroki ^d   Kasugai, Kunio ^b   Yoneda, Masashi ^b   Kaneko, Hiroshi ^a   Ohira, Hideki ^d  

^a FUJITA HEALTH UNIVERSITY BANTANE HOSPITAL   (Japan)

^b Fujita Health University   (Japan)

^c MIE UNIVERSITY   (Japan)

^d NAGOYA UNIVERSITY   (Japan)

Author keywords

A118G polymorphism; Health perception; IL 6; OPRM1; Proinflammatory cytokine

Indexed keywords

BETA ENDORPHIN; CYTOKINE; GAMMA INTERFERON; GENOMIC DNA; INTERLEUKIN 2; INTERLEUKIN 6; MU OPIATE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HEALTH BEHAVIOR; HETEROZYGOTE; HUMAN; IMMUNOCOMPETENT CELL; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PSYCHOPHYSIOLOGY; QUALITY OF LIFE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; ANALYSIS OF VARIANCE; CYTOKINES; FEMALE; GENOTYPE; HEALTH SURVEYS; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; QUALITY OF LIFE; RECEPTORS, OPIOID, MU;

EID: 70349083000     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2009.03.007     Document Type: Article

References (35)

1. Ackerman K.D., Martino M., Heyman R., Moyna N.M., and Rabin B.S. Stressor-induced alteration of cytokine production in multiple sclerosis patients and controls. Psychosom. Med. 60 (1998) 484-491
2. Ader R. On the development of psychoneuroimmunology. Eur. J. Pharmacol. 405 (2000) 167-176
3. Altemus M., Rao B., Dhabhar F.S., Ding W., and Granstein R.D. Stress-induced changes in skin barrier function in healthy women. J. Invest. Dermatol. 117 (2001) 309-317
4. Bart G., LaForge K.S., Borg L., Lilly C., Ho A., and Kreek M.J. Altered levels of basal cortisol in healthy subjects with a 118G allele in exon 1 of the Mu opioid receptor gene. Neuropsychopharmacology 31 (2006) 2313-2317
5. Bond C., LaForge K.S., Tian M., Melia D., Zhang S., Borg L., Gong J., Schluger J., Strong J.A., Leal S.M., Tischfield J.A., Kreek M.J., and Yu L. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc. Natl. Acad. Sci. USA 95 (1998) 9608-9613
6. Chong R.Y., Oswald L., Yang X., Uhart M., Lin P.I., and Wand G.S. The Mu-opioid receptor polymorphism A118G predicts cortisol responses to naloxone and stress. Neuropsychopharmacology 31 (2006) 204-211
7. Chou W.Y., Yang L.C., Lu H.F., Ko J.Y., Wang C.H., Lin S.H., Lee T.H., Concejero A., and Hsu C.J. Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty. Acta Anaesthesiol. Scand. 50 (2006) 787-792
8. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., and Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9 (2008) 46-56 (Review)
9. Doyle W.J., Gentile D.A., and Cohen S. Emotional style, nasal cytokines, and illness expression after experimental rhinovirus exposure. Brain Behav. Immun. 20 (2006) 175-181
10. Edwards K.M., Burns V.E., Ring C., and Carroll D. Sex differences in the interleukin-6 response to acute psychological stress. Biol. Psychol. 71 (2006) 236-239
11. Finley M.J., Happel C.M., Kaminsky D.E., and Rogers T.J. Opioid and nociceptin receptors regulate cytokine and cytokine receptor expression. Cell Immunol. 252 (2008) 146-154 (Review)
12. Fukuhara S., Bito S., Green J., Hsiao A., and Kurokawa K. Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J. Clin. Epidemiol. 51 (1998) 1037-1044
13. Fukuhara S., Ware J.E., Kosinski M., Wada S., and Gandek B. Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey. J. Clin. Epidemiol. 51 (1998) 1045-1053
14. Hayashida M., Nagashima M., Satoh Y., Katoh R., Tagami M., Ide S., Kasai S., Nishizawa D., Ogai Y., Hasegawa J., Komatsu H., Sora I., Fukuda K., Koga H., Hanaoka K., and Ikeda K. Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype. Pharmacogenomics 9 (2008) 1605-1616
15. Hernandez-Avila C.A., Covault J., Wand G., Zhang H., Gelernter J., and Kranzler HR. Population-specific effects of the Asn40Asp polymorphism at the mu-opioid receptor gene (OPRM1) on HPA-axis activation. Pharmacogenet. Genomics 17 (2007) 1031-1038
16. Hishimoto A., Cui H., Mouri K., Nushida H., Ueno Y., Maeda K., and Shirakawa O. A functional polymorphism of the micro-opioid receptor gene is associated with completed suicides. J. Neural. Transm. 115 (2008) 531-536
17. Hsueh C.M., Chen S.F., Huang H.J., Ghanta V.K., and Hiramoto R.N. Activation of mu-opioid receptors is required for the conditioned enhancement of NK cell activity. Brain Res. 737 (1996) 263-268
18. Johnson E.O., Kamilaris T.C., Chrousos G.P., and Gold P.W. Mechanisms of stress: a dynamic overview of hormonal and behavioral homeostasis. Neurosci. Biobehav. Rev. 16 (1992) 115-130
19. Lang K., Drell T.L., Niggemann B., Zänker K.S., and Entschladen F. Neurotransmitters regulate the migration and cytotoxicity in natural killer cells. Immunol. Lett. 90 (2003) 165-172
20. Lindmark E., Diderholm E., Wallentin L., and Siegbahn A. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. JAMA 286 (2001) 2107-2113
21. Lötsch J., Stuck B., and Hummel T. The human μ-opioid receptor gene polymorphism 118A > G decreases cortical activation in response to specific nociceptive stimulation. Behav. Neurosci. 120 (2006) 1218-1224
22. Mizuno T., Aoki M., Shimada Y., Inoue M., Nakaya K., Takahashi T., Itoyama Y., Kanazawa M., Utsumi A., Endo Y., Nomura T., Hiratsuka M., Mizugaki M., Goto J., Hongo M., and Fukudo S. Gender difference in association between polymorphism of serotonin transporter gene regulatory region and anxiety. J. Psychosom. Res. 60 (2006) 91-97
23. Nishizawa D., Han W., Hasegawa J., Ishida T., Numata Y., Sato T., Kawai A., and Ikeda K. Association of mu-opioid receptor gene polymorphism A118G with alcohol dependence in a Japanese population. Neuropsychobiology 53 (2006) 137-141
24. Orange J.S., and Ballas Z.K. Natural killer cells in human health and disease. Clin. Immunol. 118 (2006) 1-10 (Review)
25. Parissis J.T., Nikolaou M., Farmakis D., Paraskevaidis I.A., Bistola V., Venetsanou K., Katsaras D., Filippatos G., and Kremastinos D.T. Self-assessment of health status is associated with inflammatory activation and predicts long-term outcomes in chronic heart failure. Eur. J. Heart Fail. 11 (2009) 163-169
26. Raison C.L., Capuron L., and Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 27 (2006) 24-31 (Review)
27. Ray L.A., and Hutchison K.E. A polymorphism of the μ-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans. Alcohol Clin. Exp. Res. 28 (2004) 1789-1795
28. Ridker P.M., Rifai N., Stampfer M.J., and Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101 (2000) 1767-1772
29. Shalev I., Lerer E., Israel S., Uzefovsky F., Gritsenko I., Mankuta D., Ebstein R.P., and Kaitz M. BDNF Val66Met polymorphism is associated with HPA axis reactivity to psychological stress characterized by genotype and gender interactions. Psychoneuroendocrinology 34 (2009) 382-388
30. Straub R.H., Dorner M., Riedel J., Kubitza M., Van Rooijen N., Lang B., Schölmerich J., and Falk W. Tonic neurogenic inhibition of interleukin-6 secretion from murine spleen caused by opioidergic transmission. Am. J. Physiol. 274 (1998) R997-1003
31. Straub R.H., Herrmann M., Berkmiller G., Frauenholz T., Lang B., Schölmerich J., and Falk W. Neuronal regulation of interleukin 6 secretion in murine spleen: adrenergic and opioidergic control. J. Neurochem. 68 (1997) 1633-1639
32. Trescot A.M., Datta S., Lee M., and Hansen H. Opioid pharmacology. Pain Physician 11 (2008) S133-S153 (Review)
33. van Gool J., van Vugt H., Helle M., and Aarden L.A. The relation among stress, adrenalin, interleukin 6 and acute phase proteins in the rat. Clin. Immunol. Immunopathol. 57 (1990) 200-210
34. von Känel R., Kudielka B.M., Preckel D., Hanebuth D., and Fischer J.E. Delayed response and lack of habituation in plasma interleukin-6 to acute mental stress in men. Brain Behav. Immun. 20 (2006) 40-48
35. Zhou D., Kusnecov A.W., Shurin M.R., DePaoli M., and Rabin B.S. Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology 133 (1993) 2523-2530